Abstract 159: Trends in Dual Antiplatelet Therapy Prescription Patterns for Secondary Prevention in Patients With Noncardioembolic Ischemic Stroke

Xian, Ying; Shrader, Peter; E. Smith, Eric; C. Fonarow, Gregg; L. Bhatt, Deepak; Matsouaka, Roland; L. Lytle, Barbara; H. Schwamm, Lee; D. Peterson, Eric

doi:10.1161/str.51.suppl_1.159

Public

Abstract 159: Trends in Dual Antiplatelet Therapy Prescription Patterns for Secondary Prevention in Patients With Noncardioembolic Ischemic Stroke

Published in Stroke • Feb 1, 2020

Authors:

Ying Xian

Peter Shrader

Eric E. Smith

Abstract

Background: The recommendations for dual antiplatelet (DAPT aspirin + clopidogrel) for secondary stroke prevention has evolved over time. Following the publication of CHANCE trial (07/2013), the AHA/ASA updated the DAPT recommendations from Class III harm (10/2010) for patient with noncardioembolic ...

Subject

Medicine

Guideline

Clopidogrel

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!